Cellebrite DI Q2 Adj. EPS $0.05 Beats $0.03 Estimate, Sales $76.68M Beat $72.46M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cellebrite DI (NASDAQ:CLBT) reported Q2 earnings of $0.05 per share, beating the analyst consensus estimate of $0.03 by 66.67%. The company also reported quarterly sales of $76.68 million, surpassing the analyst consensus estimate of $72.46 million by 5.82%. This represents a 22.54% increase over sales of $62.57 million in the same period last year.
August 08, 2023 | 11:07 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cellebrite DI's Q2 earnings and sales exceeded analyst estimates, which could lead to a positive market reaction.
Cellebrite DI's Q2 earnings and sales have surpassed analyst estimates, which is typically a positive signal to the market. The 22.54% YoY increase in sales also indicates strong growth, which could further boost investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100